Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Goetz

Showing results (131-140 of 265) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifenMatthew P Goetz, Vera J Suman, James N Ingle, et al.
NPJ Breast Cancer|April 26, 2024
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE studyMatthew P Goetz, Irfan Cicin, Laura Testa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imagingRajini Katipamula, Amy C Degnim, Tanya Hoskin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2018
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasisJordan M Reese, Elizabeth S Bruinsma, Adam W Nelson, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
NPJ Breast Cancer|June 19, 2021
Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)Yongxian Zhuang, Jordan M Grainger, Peter T Vedell, et al.
Molecular Cancer Therapeutics|April 17, 2008
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomyJudith A Gilbert, Matthew P Goetz, Carol A Reynolds, et al.
Cancer Research|December 5, 2022
Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast CancerLixuan Wei, Huanyao Gao, Jia Yu, et al.
JAMA Network Open|February 3, 2023
Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010Carolyn M Larsen, Mariana Garcia Arango, Harika Dasari, et al.
Human Immunology|June 18, 2020
Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA typeAnn M Moyer, Brian Dukek, Patti Duellman, et al.
Pageof 27

Showing results (131-140 of 265) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifenMatthew P Goetz, Vera J Suman, James N Ingle, et al.
NPJ Breast Cancer|April 26, 2024
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE studyMatthew P Goetz, Irfan Cicin, Laura Testa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imagingRajini Katipamula, Amy C Degnim, Tanya Hoskin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2018
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasisJordan M Reese, Elizabeth S Bruinsma, Adam W Nelson, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
NPJ Breast Cancer|June 19, 2021
Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)Yongxian Zhuang, Jordan M Grainger, Peter T Vedell, et al.
Molecular Cancer Therapeutics|April 17, 2008
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomyJudith A Gilbert, Matthew P Goetz, Carol A Reynolds, et al.
Cancer Research|December 5, 2022
Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast CancerLixuan Wei, Huanyao Gao, Jia Yu, et al.
JAMA Network Open|February 3, 2023
Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010Carolyn M Larsen, Mariana Garcia Arango, Harika Dasari, et al.
Human Immunology|June 18, 2020
Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA typeAnn M Moyer, Brian Dukek, Patti Duellman, et al.
Pageof 27